EGFR and lung adenocarcinoma: Transcriptional upregulation of A3B and downregulation of UNG were subsequently validated in multiple oncogenic EGFR-driven cellular models of lung adenocarcinoma at both the RNA (Fig. 5c,d) and protein levels (Fig. 5e).